Endogenous ligands for sigma opioid receptors in the brain (“sigmaphin”): Evidence from binding assays

Abstract

Two endogenous ligands which interact preferentially with the sigma opioid receptors were identified from the guinea- pig brain extract in a Sephadex G-50 fractionation. These two ligands inhibited more potently the binding of [ 3H]SKF-10047 to sigma opioid receptors than [ 3H]naloxone to mu opioid receptors, [ 3H]ethylketocyclazocine to kappa opioid receptors and [ 3H]DADLE to delta opioid receptors. In the phencyclidine receptor assay, these two ligands were almost inactive. Incubation of these ligands with trypsin destroyed at least 50% of the activities in the sigma opioid receptor assay. Both ligands inhibited the sigma binding in a dose-dependent manner. The inhibition could be eliminated when the two ligands were removed from incubation media by extensive washings. It is therefore concluded that sigma opioid receptors are not phencyclidine receptors and that endogenous ligands for sigma opioid receptors may exist in the brain.